U.S. FDA advises manufacturers to add a spike protein component of the Omicron subvariants BA.4 and BA.5 to their prototype vaccines for fall boosters.
Canadian researchers clarify SABA and budesonide/formoterol overuse as relievers and translate Canadian Thoracic Society guidelines into clinical practice.